{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:36:16Z","timestamp":1792697776142,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T00:00:00Z","timestamp":1383782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s13318-013-0158-5","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T09:35:54Z","timestamp":1383730554000},"page":"183-193","source":"Crossref","is-referenced-by-count":26,"title":["Preparation and in vitro\/in vivo evaluation of felodipine nanosuspension"],"prefix":"10.1007","volume":"39","author":[{"given":"Bhanu P.","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malay K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"issue":"3","key":"158_CR1","first-page":"144","volume":"4","author":"MA Aboul-Einien","year":"2009","unstructured":"Aboul-Einien MA (2009) Formulation and evaluation of felodipine in soft gels with a solubilized core. Asian J Pharm Sci 4(3):144\u2013160","journal-title":"Asian J Pharm Sci"},{"key":"158_CR2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018920412020","volume":"11","author":"B Abrahamsson","year":"1994","unstructured":"Abrahamsson B, Johansson D, Torstensson A, Wingstrand K (1994) Evaluation of solubilizers in the drug release of hydrophilic matrix extended-release tablets of felodipine. Pharm Res 11:1093\u20131097","journal-title":"Pharm Res"},{"key":"158_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1461-5347(99)00177-7","volume":"2","author":"BH Bernhard","year":"1999","unstructured":"Bernhard BH, Muller RH (1999) Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs. Pharm Sci Tech Today 2:336\u2013339","journal-title":"Pharm Sci Tech Today"},{"issue":"931","key":"158_CR4","first-page":"934","volume":"80","author":"I Diez","year":"1991","unstructured":"Diez I, Colom H, Moreno J, Obach R, Peraire C, Domenech JA (1991) Comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J Pharm Sci 80(931):934","journal-title":"J Pharm Sci"},{"key":"158_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2005.05.017","volume":"301","author":"W Dong-Han","year":"2005","unstructured":"Dong-Han W, Min-Soo K, Sibeum L, Jeong-Sook P, Sung-Joo H (2005) Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti solvent precipitation process. Int J Pharm 301:199\u2013208","journal-title":"Int J Pharm"},{"key":"158_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2006.02.004","volume":"63","author":"D Douroumis","year":"2006","unstructured":"Douroumis D, Fahr A (2006) Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique. Eur J Pharm Biopharm 63:173\u2013175","journal-title":"Eur J Pharm Biopharm"},{"key":"158_CR7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jat\/21.5.388","volume":"21","author":"AB Durol","year":"1997","unstructured":"Durol AB, Greenblatt DJ (1997) Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: application to single-dose pharmacokinetic studies. J Anal Toxicol 21:388\u2013392","journal-title":"J Anal Toxicol"},{"key":"158_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2007.12.016","volume":"355","author":"L Gao","year":"2008","unstructured":"Gao L, Zhang D, Chen M, Duan C, Dai W, Jia L, Zhao W (2008) Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions, Int J Pharm 355:321\u2013327","journal-title":"Int J Pharm"},{"key":"158_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2012.10.004","volume":"48","author":"M George","year":"2013","unstructured":"George M, Ghosh I (2013) Identifying the correlation between drug\/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci 48:142\u2013152","journal-title":"Eur J Pharm Sci"},{"key":"158_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2009.02.015","volume":"374","author":"Z Hai-Xia","year":"2009","unstructured":"Hai-Xia Z, Jie-X W, Zhi-Bing Z, Yuan L, Zhi-Gang S, Jian-Feng C (2009) Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm 374:106\u2013113","journal-title":"Int J Pharm"},{"key":"158_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.03.029","volume":"375","author":"SMA Hany","year":"2009","unstructured":"Hany SMA, Peter Y, Nicholas B (2009) Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm 375:107\u2013113","journal-title":"Int J Pharm"},{"key":"158_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-5173(89)90069-0","volume":"51","author":"RJ Hintz","year":"1989","unstructured":"Hintz RJ, Johnson KC (1989) The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm 51:9\u201317","journal-title":"Int J Pharm"},{"key":"158_CR13","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W","volume":"40","author":"D Horn","year":"2001","unstructured":"Horn D, Rieger J (2001) Organic nanoparticles in the aqueous phase-theory, experiment and use. Angew Chem Int Ed 40:4330\u20134361","journal-title":"Angew Chem Int Ed"},{"key":"158_CR14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/03639040500215958","volume":"31","author":"E Karavas","year":"2005","unstructured":"Karavas E, Ktistis G, Xenakis A, Georgarakis E (2005) Miscibility behaviour and formation mechanism of stabilized felodipine polivinylpyrrolidone amorphous nanodispersions. Drug Dev Ind Pharm 31:473\u2013489","journal-title":"Drug Dev Ind Pharm"},{"key":"158_CR15","first-page":"3","volume":"62","author":"CM Keck","year":"2006","unstructured":"Keck CM, Muller RH (2006) Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur J Pharm Sci 62:3\u201316","journal-title":"Eur J Pharm Sci"},{"key":"158_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(91)90123-6","volume":"68","author":"J Kerc","year":"1991","unstructured":"Kerc J, Srcic S, Mohar M, Smid-Korbar J (1991) Some physicochemical properties of glassy felodipine. Int J Pharm 68:25\u201333","journal-title":"Int J Pharm"},{"key":"158_CR17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"F Kesisoglou","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y (2007) Nanosizing\u2014oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631\u2013644","journal-title":"Adv Drug Deliv Rev"},{"key":"158_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/02652040400015346","volume":"22","author":"BK Kim","year":"2005","unstructured":"Kim BK, Hwang SJ, Park JB, Park HJ (2005) Characteristics of felodipine-located poly(epsilon-caprolactone) microparticles. J. Microenc 22:193\u2013203","journal-title":"J. Microenc"},{"key":"158_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/02652040309178060","volume":"20","author":"DW Lee","year":"2003","unstructured":"Lee DW, Hwang SJ, Park JB, Park HJ (2003) Preparation and release characteristics of polymer-coated and blended alginate microspheres. J Microenc 20:179\u2013192","journal-title":"J Microenc"},{"key":"158_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2007.04.025","volume":"342","author":"XS Li","year":"2007","unstructured":"Li XS, Wang JX, Shen ZG, Zhang PY, Chen JF, Yun J (2007) Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. Int J Pharm 342:26\u201332","journal-title":"Int J Pharm"},{"key":"158_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2006.03.054","volume":"320","author":"M Louhi-Kultanen","year":"2006","unstructured":"Louhi-Kultanen M, Karjalainen M, Rantanen J, Huhtanen M, Kallas J (2006) Crystallization of glycine with ultrasound. Int J Pharm 320:23\u201329","journal-title":"Int J Pharm"},{"key":"158_CR23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ultsonch.2006.12.004","volume":"14","author":"MD Luque de Castro","year":"2007","unstructured":"Luque de Castro MD, Priego-Capote F (2007) Ultrasound-assisted crystallization (sonocrystallization). Ultrason Sonochem 14:717\u2013724","journal-title":"Ultrason Sonochem"},{"key":"158_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0939-6411(98)00015-0","volume":"46","author":"LV Martine","year":"1998","unstructured":"Martine LV, Laurence F, Young-Il K, Maurice H, Philippe M (1998) Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 46:137\u2013143","journal-title":"Eur J Pharm Biopharm"},{"key":"158_CR25","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1021\/mp0700211","volume":"4","author":"ME Matteucci","year":"2007","unstructured":"Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO, Johnston KP (2007) Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm 4:4782\u20134793","journal-title":"Mol Pharm"},{"key":"158_CR26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejpb.2004.03.022","volume":"58","author":"J M\u00f6schwitzer","year":"2004","unstructured":"M\u00f6schwitzer J, Achleitner G, Pomper H, Muller RH (2004) Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm 58:615\u2013619","journal-title":"Eur J Pharm Biopharm"},{"key":"158_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(97)00311-6","volume":"160","author":"RH M\u00fcller","year":"1998","unstructured":"M\u00fcller RH, Peters K (1998) Nanosuspensions for the formulation of poorly soluble drugs I. Preparation by a size-reduction technique. Int J Pharm 160:229\u2013237","journal-title":"Int J Pharm"},{"key":"158_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.supflu.2005.09.005","volume":"37","author":"P Pathak","year":"2006","unstructured":"Pathak P, Meziani MJ, Desai T, Sun Y-P (2006) Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing. J Supercrit Fluids 37:279\u2013286","journal-title":"J Supercrit Fluids"},{"key":"158_CR29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","volume":"56","author":"VB Patravale","year":"2004","unstructured":"Patravale VB, Date AA, Kulkarni RM (2004) Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56:827\u2013840","journal-title":"J Pharm Pharmacol"},{"key":"158_CR30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"BE Rabinow","year":"2004","unstructured":"Rabinow BE (2004) Nanosuspensions in drug delivery. Drug Discov 3:785\u2013796","journal-title":"Drug Discov"},{"key":"158_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-8446(98)00129-6","volume":"15","author":"E Reverchon","year":"1999","unstructured":"Reverchon E (1999) Supercritical antisolvent precipitation of micro- and nanoparticles. J Supercrit Fluids 15:1\u201321","journal-title":"J Supercrit Fluids"},{"key":"158_CR32","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1023\/B:PHAM.0000048196.61887.e5","volume":"21","author":"T Rogers","year":"2004","unstructured":"Rogers T, Gillespie IB, Hitt JE, Fransen KL, Crowl CA, Tucker CJ, Kupperblatt GB, Becker JN, Wilson DL, Todd C, Elder EJ (2004) Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs. Pharm Res 21:2048\u20132057","journal-title":"Pharm Res"},{"key":"158_CR33","author":"BP Sahu","year":"2013","unstructured":"Sahu BP, Das MK (2013) Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci. doi: 10.1007\/s13204-012-0188-3","journal-title":"Appl Nanosci"},{"key":"158_CR34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00003495-198836040-00002","volume":"36","author":"E Saltiel","year":"1988","unstructured":"Saltiel E, Ellrodt AG, Monk JP, Langley MS (1988) Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs 36:387\u2013428","journal-title":"Drugs"},{"key":"158_CR35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2007.02.005","volume":"338","author":"B Eerdenbrugh Van","year":"2007","unstructured":"Van Eerdenbrugh B, Froyen L, Martens JA, Blaton N, Augustijns P, Brewster M, Van den Mooter G (2007) Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm 338:198\u2013206","journal-title":"Int J Pharm"},{"key":"158_CR36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","volume":"364","author":"B Eerdenbrugh Van","year":"2008","unstructured":"Van Eerdenbrugh B, Van den Mooter G, Augustijns P (2008) Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64\u201375","journal-title":"Int J Pharm"},{"key":"158_CR37","first-page":"931","volume":"2","author":"PR Veerareddy","year":"2012","unstructured":"Veerareddy PR, Poluri K, Sistla R, Chaganty S, Vennishetty VK (2012) Formulation development and comparative pharmacokinetic evaluation of felodipine nanoemulsion in SD rats. Am J Pharm Tech Res 2:931\u2013945","journal-title":"Am J Pharm Tech Res"},{"key":"158_CR38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0098-2997(94)90038-8","volume":"15","author":"M Weis","year":"1994","unstructured":"Weis M, Mortensen SA, Rassing MR (1994) Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers. Mol Aspects Med 15:273\u2013280","journal-title":"Mol Aspects Med"},{"key":"158_CR39","first-page":"151","volume":"60","author":"K Wingstrand","year":"1990","unstructured":"Wingstrand K, Abrahamson B, Edgar B (1990) Bioavailability from felodipine extended-release tablets with different dissolution properties Int. J Pharm 60:151\u2013156","journal-title":"J Pharm"},{"key":"158_CR40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejps.2010.04.006","volume":"40","author":"D Xia","year":"2010","unstructured":"Xia D, Quan P, Piao H, Sun S, Yin Y, Cui F (2010) Preparation of stable nitrendipine nanosuspensions using the precipitation\u2013ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci 40:325\u2013334","journal-title":"Eur J Pharm Sci"},{"key":"158_CR41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2007.08.036","volume":"350","author":"R Xiong","year":"2008","unstructured":"Xiong R, Lu W, Li J, Wang P, Xu R, Chen T (2008) Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm 350:338\u2013343","journal-title":"Int J Pharm"},{"key":"158_CR42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijpharm.2009.11.007","volume":"386","author":"D Yuancai","year":"2010","unstructured":"Yuancai D, Wai KN, Jun H, Shoucang S, Reginald BHT (2010) A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs. Int J Pharm 386:256\u2013261","journal-title":"Int J Pharm"},{"key":"158_CR43","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1081\/DDC-120015352","volume":"28","author":"AA Zaghloul","year":"2002","unstructured":"Zaghloul AA, Gurley B, Khan M (2002) Bioavailability assessment of oral coenzyme Q10 formulations in dogs. Drug Dev Ind Pharm 28:1195\u20131200","journal-title":"Drug Dev Ind Pharm"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-013-0158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-013-0158-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-013-0158-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:44:35Z","timestamp":1559475875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-013-0158-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["158"],"URL":"https:\/\/doi.org\/10.1007\/s13318-013-0158-5","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}